Clinical Trial Update: FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating fecal microbiota transplantation (FMT) with nivolumab for patients with advanced solid cancers who have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Asan Medical Center | Conditions: Solid Carcinoma | NA | Status: RECRUITING